nhic.sgnhic.sg/.../i2d/...grant_application_form_v9.0.docx · web viewtwo softcopy submissions...

National Health Innovation Centre Singapore

Innovation to Develop (I2D) Grant

(NHIC I2D)

Application Form

SUBMISSION DATE (DD/MM/YYYY)

PRINCIPAL INVESTIGATOR

HOST INSTITUTION

HEALTHCARE CLUSTER

NHIC I2D GRANT APPLICATION FORM

GUIDELINES

For I2D Grant Application, complete the Full Proposal Application Form (NHIC-I2D-FORM-1).

Use Arial font size 11 and single spacing for all text.

Complete all sections in the full proposal form; indicate “NA” where not applicable.

Please indicate the submission date of the grant call on the cover page.

SUBMISSION DETAILS

All applications must be fully endorsed by either the PI’s respective Office Of Research/Principal’s or Director’s Office/RI ED’s Office/Institutes or equivalent, before the submission deadline.

Applications must be submitted to NHIC through the Research Office of the Principal Investigator’s (PI’s) Healthcare Cluster (or in the case of SingHealth, applications must be submitted through the SingHealth Intellectual Property Office (SHIP)).

Only applications with the following submissions received by the Grant Secretariat by the respective deadlines will be accepted:

1. Two softcopy submissions are required: i) a single Microsoft Word document, without signatures, and ii) a single PDF document, with signatures. Please ensure the latest version of NHIC Full Proposal Application form is used and name the document in the following format.

NHIC-I2D_Host Institution_PI’s Name

Please submit the softcopy to Grant Secretariat at [email protected] by Closing Date, 5pm, with the subject header “NHIC-I2D_(Name of PI’s Healthcare Cluster)_Name of PI’s Institution)”. NB: Host Institution internal submission deadline may apply, please check with your Research Office for more details.

The application may be rejected for the following reasons:

1. Incomplete application e.g. missing signatures; sections left blank, missing CVs, sections removed.2. Obsolete application form.

Late submission or revision to the submitted application will not be accepted after the closing date.

Doc No: NHIC-I2D-FORM-1 of 25Version: 9.0Effective Date: 31 January 2018

Important: Relevant privileged or confidential information should be disclosed to help convey a clear understanding of the project. However, such information must be clearly marked in the proposal. All information is treated in confidence. The information is furnished to the National Health Innovation Centre Singapore (NHIC) with the understanding that it shall be used or disclosed for evaluation, reference and reporting purposes. If your application is not successful, this form will be destroyed after the retention period deemed as appropriate by NHIC.

mailto:[email protected]


1. CATEGORY OF PROPOSAL

a. I2D Grant Application

b. New Submission Please specify if the applications/projects were funded under NHIC Joint MedTech or I2P Grant Scheme and provide details:

Application that has been previously submitted for NHIC research grants (Application ID: NHIC-I2D- )

c. Please indicate the relevant category:

BioPharma (e.g. Therapeutics, BioTechnology, Biologics, etc)

MedTech (e.g. in vitro Diagnostics (IV), MedTech Devices, Health IT & Software, etc)



2. APPLICANTS’ INFORMATIONPlease note the definitions of a Principal Investigator (PI), Co-Investigator (Co-I) and Collaborator, as indicated in the footnote. The terms of collaboration with overseas research institutions and companies must conform to NHIC’s & NMRC’s existing policies. (*please add more rows if required)

Name Role in Project (e.g. Principal Investigator1, Co-I2, Collaborator3 4

Host Institution5

% Effort within Project6

% Effort Within Own Work Commitments7

Total 100%

Outline below the role of each team member and what expertise they bring to the Project.

3. TITLE OF PROJECT (Limit to 15 words )

1 Definition of Principal Investigator (PI): The researcher who has the appropriate level of authority and the responsibility to direct the research project being supported by the grant. He/she is responsible and accountable for the proper conduct of the research project. One PI is allowed per application. He/she must hold a primary appointment in a local public hospital / public health institution / national speciality centre / Academic Medical Centre and be salaried by the institution.

2 Definition of Co-Investigator (Co-I): An individual involved in the scientific development and execution of the project, typically devotes a higher percentage of effort to the project as compared to a collaborator and is considered key personnel. He/she need to hold at least an adjunct position in a local public institution.

3 Definition of Collaborator: An individual involved in the scientific development and execution of the project, and typically devotes a higher percent of effort to the project. Researchers from overseas institutions or private companies can only participate as Collaborators.

4 Collaborator(s) are not entitled to receive directly any portion of the grant.

5 Definition of Host Institution: the body or institution or administering organization named in the Letter of Award as the “Host Institution” is

the body responsible for undertaking and managing the Research and administering the Funding.

6 Represents percentage effort spent by the team members in the project relative to his/her other team members. The total in this column must add up to 100%

7 Represents percentage effort spent by the team members on this project out of total work commitments (e.g. other grants, other teaching and administrative responsibilities, clinical work etc.)



4. FIELD OF PROJECTPlease complete the Health Research Classification (HRC) System below.

(A) Health CategoryYou may select up to 5 categories from below. Please use minimum number of codes to reflect main focus of the research

BloodCancerCardiovascularCongenital DisordersEarEyeInfectionInflammatory and Immune SystemInjuries and AccidentsMental HealthMetabolic and Endocrine

MusculoskeletalNeurologicalOral and GastrointestinalRenal and UrogenitalReproductive Health and ChildbirthRespiratorySkin StrokeGeneric Health RelevanceOther

(B) Project Activity CodePlease select up to 2 sub-codes from the following, eg, 2.1. 1 Underpinning Research

1.1 Normal biological development and functioning 1.2 Psychological and socioeconomic processes1.3 Chemical and physical sciences1.4 Methodologies and measurements1.5 Resources and infrastructure (underpinning)

2 Aetiology2.1 Biological and endogenous factors2.2 Factors relating to physical environment2.3 Psychological, social and economic factors2.4 Surveillance and distribution2.5 Research design and methodologies (aetiology)2.6 Resources and infrastructure (aetiology)

3 Prevention of Disease and Conditions, and Promotion of Well-Being

3.1 Primary prevention interventions to modify behaviours or promote well-being

3.2 Interventions to alter physical and biological environmental risks

3.3 Nutrition and chemoprevention3.4 Vaccines3.5 Resources and infrastructure (prevention)

4 Detection, Screening and Diagnosis4.1 Discovery and preclinical testing of markers and

technologies4.2 Evaluation of markers and technologies4.3 Influences and impact4.4 Population screening4.5 Resources and infrastructure (detection)

5 Management of Diseases and Conditions5.1 Individual care needs5.2 End of life care5.3 Management and decision making5.4 Resources and infrastructure (disease management)

6 Development of Treatments and Therapeutic Interventions

6.1 Pharmaceuticals6.2 Cellular and gene therapies6.3 Medical devices6.4 Surgery6.5 Radiotherapy6.6 Psychological and behavioural6.7 Physical6.8 Complementary6.9 Resources and infrastructure (development of

treatments)

7 Evaluation of Treatments and Therapeutic Interventions

7.1 Pharmaceuticals7.2 Cellular and gene therapies7.3 Medical devices7.4 Surgery7.5 Radiotherapy7.6 Psychological and behavioural7.7 Physical6.8 Complementary6.9 Resources and infrastructure (evaluation of

treatments)

8 Health and Social Care Services Research8.1 Organisation and delivery of services8.2 Health and welfare economics8.3 Policy, ethics and research governance8.4 Research design and methodologies8.5 Resources and infrastructure (health services)

5. ABSTRACTIn less than 300 words, describe in lay terms the aims, hypotheses, methodology and approach of the project proposal including its clinical impact. The abstract must be self-contained so that it can serve as a succinct and accurate description of the project proposal understood by a non-scientific/medical audience. Note that the abstract may be disclosed to other funding agencies. Please ensure the abstract is non-confidential.



6. PROJECT PROPOSALIn no more than 15 pages (page limit excludes the pictures, tables, CV section and reference section), please complete the following sections in the project proposal. Use Arial font size 11 for all text.

a. Background & Clinical Need Describe the background and the significance of the clinical need which the Technology will address. Describe the current approaches to the clinical need and their shortcomings. Who are the target patients? What is the incidence and/or prevalence? What is the total amount spent per year to

address the problem faced by these target patients?

b. Description and Impact of the Technology Give a concise description of the proposed Technology covering the following areas:

Describe the Technology and how it works. Detail the preliminary studies you have undertaken using the Technology. Why is the Technology the best solution for the clinical need? How will the Technology improve the patient experience and clinical outcomes? How does the Technology fit into the clinical workflow and current practices? How will the Technology reduce healthcare system costs? Define the regulatory strategy of the proposed Solution for entry into the first major market

c. Uniqueness & Competitive Analysis of Solution Identify competing technologies and how this Technology is superior. Outline the differentiating factor(s) of the Technology and the reason that industry would find the Technology

attractive.

d. Technology Development Plan Describe in detail the Development Plan for the Technology under this funding. Highlight any technical challenges of the proposed Development Plan. What is the contingency plan where the

technical challenges cannot be overcome? Describe the methods and management of the collaboration i.e. who will take the lead for each area, a plan for

regular meetings etc. Detail any agreements that would need to be put in place prior to starting the Development Plan.

e. Commercialisation Plan Articulate a clear commercialisation plan for the Technology (for example: out-licensing, the formation of new

commercial enterprises, co-development with industry funding (short and long term). Endorsements by potential commercial partners or investors in the project are encouraged).



f. Intellectual Property Management Provide details of the relevant Background IP for the Technology. Specifically address: i) ownership ii) any

agreements/licences covering the Background IP. Briefly describe any Foreground IP likely to be generated from the project. Describe how the Team intends to manage and exploit the IP it has filed/or intends to file. Provide a description of the Team’s track record of IP generation and commercialisation e.g. list of patents filed

(status), licences, spin-off companies etc.

References:

7. ETHICAL CONSIDERATIONS AND CONTAINMENT Fund disbursement is subjected to ethics approval if the project involves any of the below.

Please check the box Yes or No if programme involves any of the following:

Please declare the participating institutions where study requiring ethics approval is conducted:

a) Human Subject Yes No b) Use of Human Material/Animal Tissues or

Cells from Primary Donors (i.e. subject/volunteers recruited for project)

Yes No

c) Use of Commercially Available Human Material/Animal Tissues or Cells Yes No

d) Animal Experimentation Yes No e) Requirement for Containment Yes No f) Multi-centre trial(s) Yes No A copy of the ethics approval is attached Yes No



8. FUNDING

8.1 Period of Support Requested Number of months (Max. of 12 months):

8.2 Funding Request Total Amount (including Indirect Costs): SGD$ (capped at SGD 250K / project inclusive of 20% indirect costs

8.3 Budget / Justifications for Budget RequestedList the budget of the funding requested in the format below and provide the relevant justifications. Please refer to NMRC Policy Document on Financial Regulations8.

8.3.1 ManpowerBudget for all the manpower required for the project including part-time personnel and those to be shared with other projects. State whether they are existing personnel in your institution or new staff to be recruited. Please use salary scales provided by the Institution as a reference. The cost should include annual increments, National Service increment, staff welfare, medical and other related benefits as per the Human Resource policies of your institution. Please note that a Co-I cannot be supported under Manpower.

Staff Category Employing Institution

Existing/New

Pax Justification Total Cost

Total

8 NMRC Finance Regulations


http://www.nmrc.gov.sg/content/dam/nmrc_internet/documents/policiesAndGuidelines/Policy%20document%20on%20Finance%20Regulations.pdf


8.3.2 EquipmentPlease budget for all scientific equipment you need to purchase to directly carry out the project. Indicate sharing of equipment with other projects, if any. For equipment costing more than $70,000 per item, indicate the estimated utilization of the equipment (e.g. 70% usage throughout the project period, and etc.)

Qty Equipment Estimated Utilization Rate for Equipment more than $70,000 (to be justified)

Justification Total Cost

Total

8.3.3 Other Operating Expenses (OOE)This covers other expenses directly related to the project such as the purchase of animals, consumables, laboratory manuals, literature searches, and maintenance of equipment

Item Item Description Justification Total Cost

Total



8.3.4 Overseas TravelConference travel will be funded only if a presentation or an article is presented and is capped at $6,000 per trip per person per requested year. Total Overseas Travel expenses shall not exceed $12,000 per project. The presentation or article must be directly related to the project and NHIC’s support must be acknowledged. Travel for commercialization activities will also be considered by NHIC on a case-by-case basis. NB: Virement into Overseas Travel is not permitted during the grant.

Item Description Justification Total Cost

Total

8.3.5 Indirect Research Cost (IRC)Indirect research cost is provided to Host Institutions, up to a maximum of 20% of the direct costs. Please refer to Annex 1.

Item Description CostIndirect Research Cost provided to Host Institution

Total

Total Direct Costs:

(Manpower + Equipment + Other Operating Expenses + Overseas Travel)

S$

Grand Total:

(Total Direct Costs + Indirect Costs)

S$



9. MILESTONES/TIMELINEProvide the timeline and proposed milestones for the proposal. Detail reasonable 6-month and 1-year benchmarks for success.Shade the appropriate box(es) to indicate the month that a particular milestone is expected to be met. You can add or delete rows as appropriate.

Note: This section will be used to monitor the progress of the study and the milestones will be subject to review by NHIC during the grant periods. The progress of a project is a critical pre-requisite for the continued disbursement of funds

Project Milestones/DeliverablesM1

M2

M3

M4

M5

M6

M7

M8

M9

M10

M11

M12

*Please ensure that the 6-month and 12-month milestones have quantifiable measures.



10. EXPECTED OUTCOMESPlease indicate your realistic expectations on the outcomes of the I2D Grant by providing the projected number/value of each listed KPI that you will aim to achieve during and after grant ended. Please state ‘NA’ where indicator is not applicable.

*NHIC places special emphasis on these targets - you will need to satisfy at least two of these in order to be funded.

NB:Number of licenses refers to the assignment of rights to use an IP for commercial purposes resulting in economic and societal benefits.Total licensing revenue includes (i) upfront/one-time payments; (ii) recurring revenue from royalty bearing IP licenses; (iii) licensing revenue from EULA; and (iv) Number of spin-offs refers to spin-offs that demonstrate successful market validation; spin-offs must be launched on the back of an IP/technology.

KPI Category Performance IndicatorsProjected number/

value

Human Capital Number of FTE trained in translational work under this Project

Intellectual Capital

Number of Invention Disclosures filed*

Number of Patents applications filed*

Number of Patents granted*

Number of Patents commercialized/licensed*

Papers published in international journals (To state impact factor)

Presentations at international conferences

Awards for research at national and international level

Industry Relevance

Amount of Industry dollars received for this Project (cash contribution)*

Amount of Industry dollars received for this project (in-kind contribution)*

Number of Licences*

Amount of Product sales revenue generated by licensees

Number of Spin-off/Start-up companies registered*

Amount of investment raised by Spin-off/Start-up

Amount of Total Licensing revenues received.

Number of Option to license agreements executed

Project adopted by the healthcare system

Follow on funding awarded from public funding

New products or processes commercialized/deployed*



11. PRIOR FUNDING FOR TECHNOLOGY’S DEVELOPMENTPlease provide the following details for funding from all sources that has contributed to the development of the Technology. List the funding source, the PI and the outcome of the grant. Attach additional pages if necessary.

11a. Support from any industry partner(s)Please provide details on the funding or other resources provided to the Development Plan by any participating industry partner(s).

Items Supported Source of Support

Form of SupportSupport

PeriodIn-Kind2

(Yes/No)Cash

Contribution3

(SGD)

11b. List all grants applied for (e.g. NMRC, NRF, A*STAR, MOE, Clusters, etc) where outcome is pendingFor all NMRC grant applications, please indicate application ID. Please indicate all the grants applied of similar proposal where the applicant is involved as PI, Co-PI, Co-Investigator or Collaborator and provide any overlapping sections in the proposals as an Annex.

Title of Research and PI’s role in project

Application ID Funding Agency

Amount of fund applied for ($)

Support Period (Year)

Highlight if there is any potential overlap of the above funding with this application to NHIC. Note that double- dipping is strictly prohibited. For any overlap, please explain how it would be handled.



12. SUGGESTED REVIEWERSPlease suggest a minimum of two local reviewers, preferably not in the same institution. Note that they should not have any conflict of interest with or involvement in the proposed project. NHIC has the final decision on the selection of reviewers for the evaluation of the proposal.

Name of Reviewer Organisation Business Email Relationship to PI and/or Co-I (s)

Remarks:



13. TEAM MEMBERSAttach the CV of each member of the research team. Please use the format below and indicate NA if the required information is not applicable (limit to 3 pages).

Name: Title: NRIC: Email: Contact No: Fax: Current Position(s) (provide full details, e.g. joint appointments, other academic appointments including those outside of Singapore)

Percentage of time spent in Singapore every year:

Employment History

Academic qualifications (Indicate degree title, award year and institution name)

Research interests

Publications in last 5 years (include only publications of direct relevance to study, stating impact factors)

Patents held (related or unrelated to study)

Scientific Awards

Half page summary of research outcomes from all previous grants [eg. publications (full papers only for past 5 years and highlight papers relevant to study), patents, awards, etc].

For Co-Is and Collaborators, please include these two items:

Peer reviewed funding awarded as PI in last 5 years (from local and foreign agencies) Grant quantum, start and end date, funding agency and field of research

Current and previous support from NHIC, NMRC or other sources (include proposals pending approval)



14. UNDERTAKING BY PRINCIPAL INVESTIGATOR In submitting the NHIC I2D Full Proposal Application, the Principal Investigator and all Co-Investigator(s) & Collaborator(s) UNDERTAKE, on any Grant Award, to:

Declare that the Principal Investigator meets the eligibility criteria. Declare that all information is accurate and true. Declare that he/she is free from any financial conflicts of interest. Not send similar versions or part(s) of this proposal to other agencies for funding. Submit supporting documents of ethics approval obtained from the relevant Institutional Review Board

(IRB) and Animal Ethics Committee for studies involving human subjects/human tissues or cells, and animal/animal tissues or cells respectively, before any funding can be confirmed.

Be actively engaged in the execution of the research and comply with all laws, rules and regulations pertaining to safety, animal and human ethics, including the Singapore Good Clinical Practice guidelines.

Ensure that National Health Innovation Centre Singapore (NHIC) funding is acknowledged in all publications and presentations.

Ensure that all publications arising from research wholly or partly funded by NHIC will be forwarded to NHIC.

Ensure NHIC is notified of any commercialization of Intellectual Property generated wholly or partly under NHIC funding.

Ensure that the requested equipment/resources are not funded by another agency or research proposal. Ensure that there is a reasonable effort in accessing available equipment/resources within the host

institution or elsewhere within Singapore. Adhere to NHIC’s & NMRC’s general guidelines on competitive funding and NHIC’s & NMRC’s Terms

and Conditions.

---------------------------------------------------------------Name and Signature of PI Date:

----------------------------------------------------------------Name and Signature of Co-I/Collaborator* 9

Date:


Date:


Date:


Date:

(*Please add more if required)

15. UNDERTAKING BY HEAD OF DEPARTMENT (HOD) & HOST INSTITUTION OF THE PIIn submitting the Grant Application, the Institution UNDERTAKES, on any Grant Award, to:

9 *Delete as appropriate



12 *Delete as appropriate Doc No: NHIC-I2D-FORM-1 of 25Version: 9.0Effective Date: 31 January 2018


Discuss with immediate supervisor of applicant that the following will be complied with: The proposed research will be conducted in the host institution Adequate resources will be provided to the PI for the entire grant period (e.g. lab space) The PI is independently salaried by the institution for the entire period of the grant The research abides by all laws, rules and regulations pertaining to national and the institution's

research operating procedures and guidelines Confirm the accuracy and completeness of information submitted, including budget, ethics, other funding

sources, etc. Confirm that budget is clear (e.g. no double funding/ excessive purchase of equipment), and is aligned

with host institution HR and other policies. There is no financial conflict of interest.

king by Head

-----------------------------------------------------------Name and Signature of Head of Department13

--------------------------------------------------------- Name and Signature of Director of Institution14

---------------Date

---------------Date

16. of Department (HOD) & Host Institution of the PIIn submitting the Grant Application, the Institution UNDERTAKES, on any Grant Award, to:

Discuss with immediate supervisor of applicant that the following will be complied with: The proposed research will be conducted in the host institution Adequate resources will be provided to the PI for the entire grant period (e.g. lab space) The PI is independently salaried by the institution for the entire period of the grant The research abides by all laws, rules and regulations pertaining to national and the institution's research

operating procedures and guidelines Confirm the accuracy and completeness of information submitted, including budget, ethics, other funding

sources, etc. Confirm that budget is clear (e.g. no double funding/ excessive purchase of equipment), and is aligned with

host institution There is no financial conflict of interest

Annex 1 Budgeting Requirements

13 If the PI is the Head of Department, UNDERTAKING by the HOD’s Reporting officer is required.

14 If the PI is the Director of the Institution, UNDERTAKING by the Director’s Reporting officer is required.Doc No: NHIC-I2D-FORM-1 of 25Version: 9.0Effective Date: 31 January 2018


Type of Expenses Description

EOM Related Expenses

Salaries, CPF and fringe benefits including medical, dental, contribution to welfare fund, staff recruitment and related costs (e.g. the onboarding of staff, staff insurance, overtime claims, staff relocation, employment benefits, employment levy, employment pass, pre-examination medical check-up, housing allowance).

Allowable as part of overall compensation to employees provided such costs are incurred under formal established and consistently applied policies of the host Institution.

The manpower funded as part of the direct cost should be directly involved in the research work of the project.

The salaries offered to staffs should be reasonable, in line with local market benchmarks and comply with formal established pay scale of the host Institution that is consistently applied regardless of the source of funds.

Core manpower fundable under the direct cost only:

- Research fellow,

- Research engineer/scientist,

- Research assistant/associate,

- Specialist laboratory technician,

- Biostatisticians,

- Nurses, and

- Technical officer.

`

Case by case consideration will be given if the PI can justify that the required manpower should be funded under the direct manpower cost.

Unconsumed leave Provision for unconsumed leave is not allowable

Bonus / Incentive payments, Allowable as part of a total compensation package provided such payments are reasonable and are made according to a formal policy of the host Institution that is consistently applied regardless of the source of funds.




Participation of overseas experts Allowable.

Expenses incurred for overseas experts invited to participate in the project and staying in Singapore for at least 6 months per year must be budgeted separately in the project budget under the category for Visiting Professor/Expert.

For other overseas experts staying for less than 6 months per year, the cost of his/her stay is allowable if the costs are specifically provided for and approved in the project grant.

Examples of such costs are honoraria, salaries, staff relocation, settling-in allowances and other related cost

For staff relocation, settling-in allowances, etc, it will be allowable for senior expatriate R&D staff if the costs are specifically provided for and approved in the project grant.

However, superannuation contributions for such staff are not allowed under both direct cost and IRC.

PI / Co-investigators / Programme Managers EOM cost

Not allowable, unless otherwise specified for in the grant approved by MOH/NHIC.

Equipment Related ExpensesNew equipment No purchase of equipment is allowed specifically provided for in the

grant approved by NHIC.

The procurement of such equipment must be made according to the formal established and consistently applied policies of the Host Institution.

The invoices for all claims must be dated before the end of the Term

Cost of capital works, general infrastructure, general purpose IT and communication equipment, office equipment, and furniture and fittings

Not allowable under direct costs, unless specifically provided for in the grant and approved by MOH/NHIC. Examples of such costs are computers, office productivity software, PDAs, mobile phones, photocopier machines, workstations, printers, etc.

Consumables Related ExpensesConsumables Allowable.

Examples of such costs are supplies and materials, laboratory consumables, animals and drugs which are necessary for the successful execution of the funded project.

All procurement of such items must be reasonable and are made according to the formal established and consistently applied policies of




the host Institution.

Drug costs and medical procedures for patients and volunteers

Allowable.

OOE Related ExpensesBank charges Allowable as long as it is specifically related to the payments for

consumables and equipment used in the project.

Customs and import duties Allowable as long as it is specifically related to importation of consumables and equipment used in the project.

Books and specialised journals relevant to the research

Allowable as long as it is related to the research.

If the host Institution has a library, books and journals should be obtained from the library and PI should refrain from purchasing the same books or subscribing to such journals.

GST Allowable for expenses incurred for the project.

Photocopying and printing charges Allowable.

Publications Allowable.

Page charges for publication of manuscript in professional journals are allowable if they adhere to the formal established policy of the host Institution, where applicable.

The costs of reprints and publishing in other media, such as books, monographs, and pamphlets are not allowable unless specific approval has been obtained from the NMRC.

Repairs and maintenance of research equipment

Allowable if specifically budgeted for in the project and the equipment is used extensively for the benefit of the research project.

Stationery & printer consumables Allowable.

Examples of such costs are printer cartridges, etc.

Training Allowable.

Funding for training is allowable for the PI, co-PIs and the collaborators. For funding of the research personnel, it should be restricted to the personnel employed under the project grant and for training that is of direct benefit and specific to the research project.

Transportation, postage & courier services

Allowable.

This includes postage, courier and freight charges for bringing in equipment and specialised research consumables and reimbursement




for staff transportation.

Use of services, equipment rental or lab spaces within the host Institution’s central facilities

Allowable.

The cost for the use of the services and central facilities owned by the host Institution such as animal holding units, central laboratory services are allowable and must be based on host Institution’s fee schedules which are consistently applied regardless of source of funds.

Host Institution may be requested to certify that the fee structure is applied consistently.

Payment to volunteers and research patients and other related cost

Allowable for payment to volunteers and research subjects provided this is the scope of the research and has been provided for and approved in the grant. Examples of such payments may include inconvenience fees, transport and meal reimbursement, etc.

Press advertisements for patients are allowable under IRC only.

Audit Fees Not allowable. This includes both internal and external audit fees.

Entertainment & Refreshment Not allowable.

Fines and penalties Not allowable.

Legal fees Not allowable.

Outsourcing Not allowable under direct cost unless specifically provided for and approved in the grant.

Overhead expenses Not allowable unless specifically provided for in the grant and approved by the MOH/NHIC based on the nature of the research. This includes rental, utilities, facilities management, telephone charges, internet charges, etc.

Patent Application (all patent-related expenses)

Not allowable.

This includes patent application filing, maintenance, and other related cost.

Professional fees (including fees to consultants)

Not allowable unless specifically provided for in the grant and approved by the MOH/NHIC

Professional membership fees Not allowable.

This applies to PI and Co-Investigators as well as all research staff funded from the grant.

Staff retreat Not allowable.

Non-cash items such as depreciation cost, amortization cost, loss on revaluation, etc.

Not allowable

Overseas Travel ExpensesLocal & Overseas conferences Allowable, if conference is directly relevant to the research area or

necessary to accomplish the project objectives for PI, co-investigators, collaborators, researchers and research students funded under the




project grant.

The expenses for such conferences may include registration fee for the conference, air tickets, per diem and other allowances. Such payments should be in accordance with the formal policies of the host Institution.

If the conferences are conducted overseas, the travel policy of the host Institution must be consistently adhered to. However, total expenses for travel per trip per person per requested year must not exceed $6,000. The total expenses under I2D Grant is capped at $12,000 per project.

The PI must submit a copy of the abstract when claiming reimbursement for such expenses and append to their annual/ final report.

APPENDIX

Non-Fundable ItemsEOM Related Expenses1 PI’s & co-investigators’ EOM

2 Stipends and course fees of full-time and/or part-time graduate research students

3 Superannuation contributions for senior expatriate R&D staff

OOE Related Expenses4 Fines and penalties

5 Legal fees

6 Patent-related expenses

Others7 Non cash items such as depreciation cost, amortization cost, loss on revaluation, etc.



Summary

Item Direct Cost

Indirect Research

CostNon-

Fundable

Specifically provided for

and approved in

grantEOM Related ExpensesSalaries, CPF and fringe benefits including medical, dental, contribution to welfare fund, etc.

√

Bonus / Incentive payments √Staff insurance √Unconsumed leave √Participation of overseas experts √Student attachment and top-up for research students √

Staff recruitment and related cost √

PI’s & co-investigators’ EOM√

Superannuation contributions for senior expatriate R&D staff √

Equipment Related ExpensesNew equipment √General purpose IT and communication equipment √



Item Direct Cost

Indirect Research

CostNon-

Fundable


and approved in

grantGeneral furniture and office equipment √

Consumables Related ExpensesConsumables (e.g. supplies and materials, laboratory consumables, animals, and drugs) √

OOE Related ExpensesBank charges √Customs and import duties √Books and specialised journals relevant to the research √

GST √Outsourcing √Photocopying and printing charges √Publications √Repairs and maintenance of research equipment √

Stationery & printer consumables √Training √Transportation, postage & courier services √Use of services, equipment rental or lab spaces within the host Institution’s central facilities

√

Volunteers and research patients and other related cost √

Press advertisements for patients √Audit fees √Entertainment & refreshment √Insurance premiums √Overhead expenses (eg. rental, utilities, telephone charges, facilities management, repairs and maintenance, etc) √

Professional fees (including fees to consultants) √Professional membership fees of PIs /RFs /RAs funded from the grant √

Staff retreat √Fines and penalties √Legal fees √Patent-related expenses √



Item Direct Cost

Indirect Research

CostNon-

Fundable


and approved in

grantCost of capital works and general infrastructure √

Overseas Travel Related ExpensesLocal & overseas conferences

√

OthersNon cash items such as depreciation cost, amortization cost, loss on revaluation, etc √


nhic.sgnhic.sg/.../i2d/...grant_application_form_v9.0.docx · web viewtwo softcopy submissions...

Documents